REG3G and neoplasm: Consistent with results obtained from MLR described above, these results imply that Reg3g initially suppressed maturation of DCs and subsequently interrupted cross-priming of CD8+ T-cell responses, ultimately contributing to the development of an aberrant tumor immune microenvironment.